Five things to know:
1. OrthoSpin raised $5 million in series B financing for its orthopedic fixation system.
2. Johnson & Johnson led the investment round with The Trendlines Group. OrthoSpin is part of the Trendlines portfolio.
3. This is Johnson & Johnson’s second investment in OrthoSpin; it led a $3 million investment round in July 2018.
4. OrthoSpin will use the funding to accelerate development and clinical use of its Generation 2 smart external fixation system, which is designed to reduce the need for in-person follow-up care, as well as dependency on patient compliance.
5. OrthoSpin’s Generation 1 system gained FDA clearance in September 2019. It automatically adjusts and lengthens struts in accordance with prescribed treatment regimens.
More articles on devices:
Physician group furloughs, layoffs, hours cut: economic responses to the pandemic
15 new COVID-19 cases linked to orthopedic practice in Alaska
Orthopedic surgeons among specialists called to treat COVID-19 patients in NYC
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
